Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients

Saudi Pharmaceutical Journal

Volumn 23, Issue 3, 2015, Pages 250-256

  Aleidi, Shereen ^a   Issa, Ala ^a   Bustanji, Haidar ^b   Khalil, Mohammad ^a   Bustanji, Yasser ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b National Center for Diabetes Endocrinology and Genetics Jordan   (Jordan)

Author keywords

Abdominal obesity; Adiponectin; Diabetes mellitus; Gender; Insulin resistance; Jordan

Indexed keywords

ADIPONECTIN;

ABDOMINAL OBESITY; ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

EID: 84930539669     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2014.11.011     Document Type: Article

References (27)

1. Adipo Bioscience Incorporation, 2012. Product Sheet Human Adiponectin (Total) ELISA Kit. http://www.Adipobioscience.com.
2. Ajlouni K., Khader Y.S., Batieha A., Ajlouni H., El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J. Diabetes Complications 2008, 22:317-324.
3. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 2012, 425:560-564.
4. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., Kahn C.R. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 2002, 3:25-38.
5. Bottner A., Kratzsch J., Muller G., Kapellen T.M., Bluher S., Keller E., Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 2004, 89:4053-4061.
6. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
7. Cnop M., Landchild M.J., Vidal J., Havel P.J., Knowles N.G., Carr D.R., Kahn S.E. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002, 51:1005-1015.
8. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
9. Fagerberg B., Kellis D., Bergstrom G., Behre C.J. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women. J. Int. Med. 2011, 269:636-643.
10. Gierach M., Gierach J., Ewertowska M., Arndt A., Junik R. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinol. 2014, 2014:514589.
11. Gil-Campos M., Canete R.R., Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin. Nutr. 2004, 23:963-974.
12. Han S.H., Sakuma I., Shin E.K., Koh K.K. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog. Cardiovasc. Dis. 2009, 52:126-140.
13. Heiker J.T., Kosel D., Beck-Sickinger A.G. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors. Biol. Chem. 2010, 391:1005-1018.
14. Isobe T., Saitoh S., Takagi S., Takeuchi H., Chiba Y., Katoh N., Shimamoto K. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur. J. Endocrinol. 2005, 153:91-98.
15. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
16. Khader Y., Batieha A., Ajlouni H., El-Khateeb M., Ajlouni K. Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab. Syndr. Relat. Disord. 2008, 6:113-120.
17. Mohammadzadeh G., Ghaffari M.A. Additional effect of diabetes mellitus type 2 on the risk of coronary artery disease: role of serum adiponectin. Iran Red. Crescent Med. J. 2014, 16:e8742.
18. Nayak B.S., Ramsingh D., Gooding S., Legall G., Bissram S., Mohammed A., Figaro K. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Prim. Care Diabetes 2010, 4:187-192.
19. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
20. Oh D.K., Ciaraldi T., Henry R.R. Adiponectin in health and disease. Diabetes Obes. Metab. 2007, 9:282-289.
21. Schulze M.B., Rimm E.B., Shai I., Rifai N., Hu F.B. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004, 27:1680-1687.
22. Semple R.K., Soos M.A., Luan J., Mitchell C.S., Wilson J.C., Gurnell M., O'Rahilly S. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J. Clin. Endocrinol. Metab. 2006, 91:3219-3223.
23. Semple R.K., Halberg N.H., Burling K., Soos M.A., Schraw T., Luan J., O'Rahilly S. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007, 56:1712-1717.
24. Semple R.K., Cochran E.K., Soos M.A., Burling K.A., Savage D.B., Gorden P., O'Rahilly S. Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance. Diabetes Care 2008, 31:977-979.
25. Sheng T., Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. J. Genet. Genomics. 2008, 35:321-326.
26. Simpson F., Whitehead J.P. Adiponectin-it's all about the modifications. Int. J. Biochem. Cell Biol. 2010, 42:785-788.
27. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.